NCT06586619 A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
| NCT ID | NCT06586619 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida International University |
| Condition | Depressive Symptoms |
| Study Type | INTERVENTIONAL |
| Enrollment | 326 participants |
| Start Date | 2025-08-04 |
| Primary Completion | 2029-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 326 participants in total. It began in 2025-08-04 with a primary completion date of 2029-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized clinical trial is to learn if tai chi/qigong decreases depressive symptoms among older people living with HIV compared to a health education class. The main questions it aims to answer are: Does tai chi/qigong reduce depressive symptoms among older people living with HIV more than a health education class? What are the behavioral, psychological, and biological mechanisms in which tai chi/qigong affects depressive symptoms? Does tai chi/qigong affect depressive symptoms among older people living with HIV differently for men compared to women? Researchers will compare a 12-week, twice a week remotely delivered tai chi/qigong intervention to a health education class of the same duration to determine if it improves depressive symptoms among older people living with HIV. Participants will: Attend either a tai chi/qigong class twice a week for 12 weeks or a health education class of the same duration delivered via Zoom. Each class will be 45-60 minutes in length. Participate in 3 separate interviewer-administered interviews: at the time of enrollment, 3 months after the last class, and 9 months after the last class. Keep a tracking log of their home practice of tai chi/qigong (only participants in the intervention group). Use a biosensor (an earlobe sensor or chest strap) to measure their heart variability. Go to their local lab (e.g., Quest or Labcorp) for blood draw at the time of enrollment and at 9 month post intervention (this will only be a subset of participants).
Eligibility Criteria
Inclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. The ability to provide consent assessed by the GAIN Cognitive Impairment Scale 2. Provision of signed and dated informed consent form 3. Must be 50 - 75 years old. 4. Must have been diagnosed with HIV by a healthcare professional (status confirmed at baseline by an uploaded picture of a recent lab report or medication bottle with name), 5. Must have reliable internet access, 6. Must have a smart phone 7. No substantial experience (regular weekly practice for more than 3 months in the past 12 months) with mind-body interventions, 8. Willing to participate for the length of the 12-week intervention and follow up assessments (a total of 12 months). 9. Must report stable housing for the past 60 days and the next 60 days; 10. Must have mild to moderate depressive symptoms (a score more than 5 but less than 19 on the PHQ-9 scale) 11. Must speak and understand English Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Reports high risk for suicide based on the CCSR screening tool. 2. Has participated in a study on mental health in the last 12 months. 3. Currently exercising at least 150 minutes a week
Contact & Investigator
Gladys E Ibanez, Ph.D.
PRINCIPAL INVESTIGATOR
Florida International University
Frequently Asked Questions
Who can join the NCT06586619 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 75 Years, studying Depressive Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06586619 currently recruiting?
Yes, NCT06586619 is actively recruiting participants. Contact the research team at gibanez@fiu.edu for enrollment information.
Where is the NCT06586619 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT06586619 clinical trial?
NCT06586619 is sponsored by Florida International University. The principal investigator is Gladys E Ibanez, Ph.D. at Florida International University. The trial plans to enroll 326 participants.